439 related articles for article (PubMed ID: 24528105)
41. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
42. Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model.
Botte DA; Noronha IL; Malheiros DM; Peixoto TV; de Mello SB
Clin Exp Immunol; 2014 Aug; 177(2):381-90. PubMed ID: 24666423
[TBL] [Abstract][Full Text] [Related]
43. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
Renner K; Hermann FJ; Schmidbauer K; Talke Y; Rodriguez Gomez M; Schiechl G; Schlossmann J; Brühl H; Anders HJ; Mack M
Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743
[TBL] [Abstract][Full Text] [Related]
44. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.
Jacob N; Guo S; Mathian A; Koss MN; Gindea S; Putterman C; Jacob CO; Stohl W
J Immunol; 2011 Apr; 186(8):4984-93. PubMed ID: 21383240
[TBL] [Abstract][Full Text] [Related]
45. IL-17 promotes murine lupus.
Amarilyo G; Lourenço EV; Shi FD; La Cava A
J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
[TBL] [Abstract][Full Text] [Related]
46. Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.
Chalmers SA; Chitu V; Herlitz LC; Sahu R; Stanley ER; Putterman C
J Autoimmun; 2015 Feb; 57():42-52. PubMed ID: 25554644
[TBL] [Abstract][Full Text] [Related]
47. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
[TBL] [Abstract][Full Text] [Related]
48. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Xiang L; Liu A; Xu G
Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
[TBL] [Abstract][Full Text] [Related]
49. Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.
Jacob CO; Guo S; Jacob N; Pawar RD; Putterman C; Quinn WJ; Cancro MP; Migone TS; Stohl W
Arthritis Rheum; 2012 May; 64(5):1610-9. PubMed ID: 22127792
[TBL] [Abstract][Full Text] [Related]
50. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus.
Wang H; Knight JS; Hodgin JB; Wang J; Guo C; Kleiman K; Eitzman DT
Sci Rep; 2016 Jun; 6():28997. PubMed ID: 27357136
[TBL] [Abstract][Full Text] [Related]
51. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
Yoshida H; Satoh M; Behney KM; Lee CG; Richards HB; Shaheen VM; Yang JQ; Singh RR; Reeves WH
Arthritis Rheum; 2002 Aug; 46(8):2235-44. PubMed ID: 12209530
[TBL] [Abstract][Full Text] [Related]
52. Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus.
Pannu N; Bhatnagar A
Immunobiology; 2020 Jan; 225(1):151871. PubMed ID: 31780314
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
[TBL] [Abstract][Full Text] [Related]
54. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
[TBL] [Abstract][Full Text] [Related]
55. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
56. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
Satoh M; Kumar A; Kanwar YS; Reeves WH
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10934-8. PubMed ID: 7479913
[TBL] [Abstract][Full Text] [Related]
57. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.
Liu X; Jiao Y; Cui B; Gao X; Xu J; Zhao Y
Lupus; 2016 Oct; 25(11):1180-9. PubMed ID: 27125291
[TBL] [Abstract][Full Text] [Related]
58. Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands
Liang CL; Jiang H; Feng W; Liu H; Han L; Chen Y; Zhang Q; Zheng F; Lu CJ; Dai Z
Front Immunol; 2021; 12():683249. PubMed ID: 34290705
[TBL] [Abstract][Full Text] [Related]
59. Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.
Lee JY; Madany E; El Kadi N; Pandya S; Ng K; Yamashita M; Jefferies CA; Gibb DR
Front Immunol; 2020; 11():584254. PubMed ID: 33101313
[TBL] [Abstract][Full Text] [Related]
60. Aconitine: A potential novel treatment for systemic lupus erythematosus.
Li X; Gu L; Yang L; Zhang D; Shen J
J Pharmacol Sci; 2017 Mar; 133(3):115-121. PubMed ID: 28302448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
